|
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
|
journal
|
June 2017 |
|
Association of In Vivo [ 18 F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
|
journal
|
April 2017 |
|
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
|
journal
|
August 2019 |
|
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
|
journal
|
August 2021 |
|
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease
|
journal
|
January 2002 |
|
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
|
journal
|
October 2012 |
|
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum: Tau and Amyloid in AD
|
journal
|
July 2016 |
|
Longitudinal tau accumulation and atrophy in aging and alzheimer disease: Tau-PET and Atrophy
|
journal
|
January 2019 |
|
Neuropathological stageing of Alzheimer-related changes
|
journal
|
September 1991 |
|
Primary age-related tauopathy (PART): a common pathology associated with human aging
|
journal
|
October 2014 |
|
Functional Alterations in Memory Networks in Early Alzheimer’s Disease
|
journal
|
January 2010 |
|
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
|
journal
|
January 2010 |
|
Enhanced Tau Aggregation in the Presence of Amyloid β
|
journal
|
July 2017 |
|
Predicting brain atrophy from tau pathology: a summary of clinical findings and their translation into personalized models
|
journal
|
January 2021 |
|
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
|
journal
|
March 2017 |
|
Biomarkers for tau pathology
|
journal
|
June 2019 |
|
Unified segmentation
|
journal
|
July 2005 |
|
Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant
|
journal
|
January 2012 |
|
Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
|
journal
|
July 2009 |
|
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
|
journal
|
November 2014 |
|
PET Imaging of Tau Deposition in the Aging Human Brain
|
journal
|
March 2016 |
|
Synthesis and Evaluation of 11 C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
|
journal
|
June 2003 |
|
Physiological release of endogenous tau is stimulated by neuronal activity
|
journal
|
February 2013 |
|
Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
|
journal
|
December 2017 |
|
Neuronal activity enhances tau propagation and tau pathology in vivo
|
journal
|
June 2016 |
|
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
|
journal
|
December 2004 |
|
Aβ-induced vulnerability propagates via the brain’s default mode network
|
journal
|
June 2019 |
|
Tau deposition is associated with functional isolation of the hippocampus in aging
|
journal
|
October 2019 |
|
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
|
journal
|
May 2020 |
|
Tau-targeting therapies for Alzheimer disease
|
journal
|
June 2018 |
|
Imaging the evolution and pathophysiology of Alzheimer disease
|
journal
|
September 2018 |
|
An empirical measure of resilience explains individual differences in the effect of tau pathology on memory change in aging
|
journal
|
February 2023 |
|
Early stages of tau pathology and its associations with functional connectivity, atrophy and memory
|
journal
|
March 2021 |
|
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
|
journal
|
May 2012 |
|
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
|
journal
|
May 2015 |
|
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
|
journal
|
October 2017 |
|
Neuropathology of Cognitively Normal Elderly
|
journal
|
November 2003 |
|
Regularization and variable selection via the elastic net
|
journal
|
April 2005 |
|
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
|
journal
|
July 2011 |
|
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
|
journal
|
January 2020 |
|
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
|
journal
|
January 2021 |
|
Tau PET imaging: present and future directions
|
journal
|
February 2017 |
|
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults
|
journal
|
July 2019 |
|
Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition
|
journal
|
April 2022 |
|
Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults
|
journal
|
April 2022 |
|
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB
|
journal
|
February 2010 |
|
Meta-analysis of amyloid-cognition relations in cognitively normal older adults
|
journal
|
April 2013 |
|
Distinct Factors Drive the Spatiotemporal Progression of Tau Pathology in Older Adults
|
journal
|
December 2021 |
|
Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
|
journal
|
November 2017 |
|
Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults
|
journal
|
November 2020 |
|
Reference Tissue–Based Kinetic Evaluation of 18 F-AV-1451 for Tau Imaging
|
journal
|
September 2016 |
|
Relation of neuropathology with cognitive decline among older persons without dementia
|
journal
|
January 2013 |